By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Vitamin K2

Vitamin K2

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|679 words

What is Vitamin K2?

Vitamin K2 is a fat-soluble vitamin that belongs to the vitamin K family of compounds essential for human health. Unlike vitamin K1 (phylloquinone), which is primarily found in leafy green vegetables, vitamin K2 (menaquinone) is produced by bacteria and found in fermented foods and animal products. It plays a crucial role in blood clotting, bone metabolism, and cardiovascular health.

Uses

Bone health support: Vitamin K2 helps activate osteocalcin, a protein that binds calcium to bones, potentially reducing fracture risk and supporting bone density.

Cardiovascular health: May help prevent calcium deposits in arteries by activating matrix Gla protein, which inhibits arterial calcification.

Blood clotting support: Works with other vitamin K compounds to support the production of clotting factors necessary for proper blood coagulation.

Submit Your Paper
GMJ_Submit_Banner

Dental health: Supports tooth mineralization and may help prevent dental decay by promoting proper calcium utilization.

Complement to vitamin D and calcium: Often used alongside these nutrients to optimize calcium metabolism and bone health.

How it works

Vitamin K2 functions as a cofactor for the enzyme gamma-glutamyl carboxylase, which activates vitamin K-dependent proteins throughout the body. These proteins, including osteocalcin in bones and matrix Gla protein in blood vessels, require vitamin K2 to properly bind and direct calcium to appropriate tissues. This mechanism helps ensure calcium is deposited in bones and teeth rather than accumulating in soft tissues like arteries.

Side effects

Common side effects:

  • Upset stomach
  • Nausea
  • Diarrhea
  • Stomach cramps
  • Headache
  • Skin reactions at injection sites (if administered by injection)
  • Taste changes
  • Dizziness

Serious side effects:

  • Severe allergic reactions (rash, difficulty breathing, swelling)
  • Unusual bleeding or bruising
  • Jaundice or liver problems
  • Blood clot formation (rare)
  • Hemolytic anemia (very rare)

Warnings and precautions

Pregnancy and breastfeeding: Generally considered safe when taken in appropriate doses, but pregnant and nursing women should consult healthcare providers before supplementation.

Blood clotting disorders: Individuals with clotting disorders or those at risk of blood clots should use caution and medical supervision.

Liver disease: People with liver conditions may have altered vitamin K metabolism and should consult their healthcare provider.

Surgical procedures: May need to be discontinued before surgery due to effects on blood clotting.

Kidney disease: Those with kidney problems should monitor usage as altered mineral metabolism may affect vitamin K requirements.

Interactions

Warfarin and anticoagulants: Can reduce the effectiveness of blood thinners by promoting clotting factor production.

Antibiotics: Broad-spectrum antibiotics may reduce vitamin K2 production by intestinal bacteria.

Cholestyramine and bile acid sequestrants: These medications can reduce fat-soluble vitamin absorption, including vitamin K2.

Orlistat: This weight-loss medication reduces fat absorption and may decrease vitamin K2 uptake.

High-dose vitamin A: May interfere with vitamin K metabolism and function.

High-dose vitamin E: Can antagonize vitamin K function and increase bleeding risk.

Mineral oil: Regular use can reduce absorption of fat-soluble vitamins including vitamin K2.

Calcium supplements: May work synergistically but timing of administration may affect absorption of both nutrients.

Check interactions with the GMJ Interaction Checker

Evidence summary

The evidence for vitamin K2’s benefits shows moderate evidence for bone health support, particularly in postmenopausal women and older adults. There is moderate evidence for cardiovascular benefits related to arterial health, though more long-term studies are needed. Limited evidence exists for dental health benefits, while the evidence for blood clotting support is well-established but primarily relevant for those with deficiencies. Most research has focused on the MK-7 form of vitamin K2, which appears to have better bioavailability than shorter-chain forms. For comprehensive safety information, visit supplement.ge.

Dosage

Typical adult dosages range from 45-180 micrograms daily, with most supplements containing 100-120 micrograms. The MK-7 form is often preferred due to its longer half-life and better tissue distribution. Some studies have used higher doses of 180-360 micrograms daily for specific health conditions. Dosage should always be determined by a healthcare provider based on individual needs, health status, and concurrent medications, particularly for those taking anticoagulant medications.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Vitamin K2 — View full safety profile, dosage, and evidence on supplement.ge →

Cite this page

GMJ News Desk. "Vitamin K2." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/vitamin-k2/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

In the news
Fermented Soy Foods Show Promise in Reducing Cognitive Decline Risk
In the news
  • Fermented Soy Foods Show Promise in Reducing Cognitive Decline Risk · May 22, 2026
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
E-cigarettes deliberately designed to target youth through availability and addictive features, researchers warn

New research reveals how tobacco companies systematically design e-cigarettes to maximize youth…

FDA’s Pazdur Calls for Agency Restructuring Amid China Competition and Internal Upheaval

FDA's Rick Pazdur calls for fundamental agency restructuring following internal disruption, citing…

Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations.…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Trimethoprim

By
Prof. Giorgi Pkhakadze
02/06/2026

Solifenacin

By
Prof. Giorgi Pkhakadze
02/06/2026

Sirolimus

By
Prof. Giorgi Pkhakadze
02/06/2026

Pioglitazone

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up